Filing Details
- Accession Number:
- 0000897069-24-001526
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-19 16:40:53
- Reporting Period:
- 2024-07-17
- Accepted Time:
- 2024-07-19 16:40:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1551152 | Abbvie Inc. | ABBV | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1239127 | A Richard Gonzalez | 1 N. Waukegan Road North Chicago IL 60064 | Executive Chairman Of Board | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 Par Value | Acquisiton | 2024-07-17 | 87,050 | $61.36 | 600,149 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2024-07-17 | 119,418 | $79.02 | 719,567 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Acquisiton | 2024-07-17 | 76,377 | $93.50 | 795,944 | No | 4 | M | Direct | |
| Common Stock, $0.01 Par Value | Disposition | 2024-07-17 | 282,845 | $175.00 | 513,099 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right To Buy) | Disposition | 2024-07-17 | 87,050 | $0.00 | 87,050 | $61.36 |
| Common Stock | Option (Right To Buy) | Disposition | 2024-07-17 | 119,418 | $0.00 | 119,418 | $79.02 |
| Common Stock | Option (Right To Buy) | Disposition | 2024-07-17 | 76,377 | $0.00 | 76,377 | $93.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-02-16 | 2027-02-15 | No | 4 | M | Direct |
| 59,709 | 2020-02-21 | 2029-02-20 | No | 4 | M | Direct |
| 152,755 | 2021-02-20 | 2030-02-19 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Billionaire Hedge Funds
